查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571732

雇主/職場藥物測試市場規模、佔有率、趨勢分析報告：按類型、按產品、按模式、按藥物、按最終用途、按地區、細分市場預測，2024-2030 年

Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type, By Product, By Mode, By Drug, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

雇主/職場藥物測試市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球雇主/職場藥物檢測市場規模預計將達到79.6億美元，2024年至2030年的複合年成長率為4.5，預計將成長%。推動這個市場的是越來越多的關注維持無毒品職場，以提高生產力和減少工作場所事故，進一步推動對藥物檢測服務的需求。

藥物濫用的盛行以及績效不佳和缺勤增加的相關風險正在推動雇主實施全面的藥物檢測計劃。測試方法的技術進步，例如快速且準確的檢測技術，透過提高藥物測試過程的效率和可靠性，有助於市場成長。政府舉措和資助計劃的增加進一步推動了市場的成長。例如，2022 年 12 月，美國政府頒布了《2023 年綜合撥款法案》（公法 117-328）(CAA23)。該法案將 2023 會計年度的資金分配給藥物濫用和心理健康服務管理局 (SAMHSA)，並包括加強、核准和擴大 SAMHSA 的藥物濫用和心理健康計劃的各種條款。

世界各地的許多政府正在發起宣傳活動、資助並製定計劃，以提高人們對職場藥物濫用的認知並加以預防。這些努力通常包括鼓勵或要求對員工進行藥物測試的指導方針和框架，特別是在被視為高風險的行業。因此，雇主擴大根據政府政策實施藥物檢測，並受益於遵守這些計劃所提供的激勵措施和資金。

隨著各政府機構嚴格執行藥物和酒精檢測安全法規，雇主和職場藥物檢測產品的需求預計將進一步增加。根據聯邦無毒品工作場所計畫指南，SAMHSA 藥物濫用預防中心監督HHS 認證的實驗室。這些藥物測試項目是國家安全、執法、公共衛生和安全等敏感職位的員工所必需的。政府機構和非政府組織都在實施新產品發布、合作夥伴關係和併購等策略性舉措來解決毒品使用問題，有助於市場成長。

市場的主要參與企業有：First Advantage、Laboratory Corporation of America Holdings (Labcorp)、Dragerwerk AG &Co.KGaA、Bio-Rad Laboratories, Inc.、Abbott、Clinical Reference Laboratory Inc.、Quest Diagnostics、Cordant Health Solutions、DISA Global Solutions、HireRight, LLC、OraSure Technologies, Inc.、Omega Laboratories、Psychemedics Corporation 和其他公司推出產品、收購和以專利為重點的資源，以服務全球患者和其他重要策略舉措。例如，2024 年 5 月，eMed 與 i3screen 合作，為雇主推出了新的虛擬藥物篩檢計畫。這項創新服務允許企業遠端進行藥物測試，使過程更加方便和高效。此次合作將使雇主能夠提供易於管理並快速提供結果的虛擬藥物篩檢，有助於簡化招募和合規程序。

雇主/職場藥物檢測市場報告亮點

  • 按類型分類，離職後細分市場以 2023 年 77.9% 的最大銷售佔有率引領市場。離職後藥物測試對員工進行就業後篩檢，通常會監測職場藥物政策的持續遵守。
  • 消耗品領域在 2023 年以 33.3% 的最大銷售佔有率引領市場。耗材在藥物檢測中發揮重要作用。這些產品的市場是由對高品質、合規的測試解決方案、技術進步的需求以及對維持無毒品職場的日益關注所推動的。市場上的主要企業專注於開發和提供各種消耗品，以滿足雇主和監管標準不斷變化的需求。
  • 從模式來看，尿液細分市場在 2023 年以 41.5% 的最大銷售佔有率引領市場。這是由於雇主和職場藥物檢測目的的尿液收集量增加。尿液藥物監測 (UDM) 是遵守規定治療方案和防止藥物誤用和濫用的重要工具。
  • 以藥品來看，大麻/大麻細分市場在 2023 年以 57.9% 的最大銷售佔有率引領市場。這是由於各國醫療和娛樂大麻合法化，增加了對雇主和職場的藥物檢測要求。隨著越來越多的人消費大麻，雇主和醫療保健提供者尋求檢測和監控其使用。
  • 按最終用途分類，其他專業服務業在 2023 年以 38.6% 的最高收益佔有率引領市場。各個專業服務行業的公司擴大採用藥物檢測計劃，以遵守監管要求、管理責任風險並提高職場安全。
  • 由於存在主要參與者和大量雇主/職場藥物檢測實驗室，收益佔有率Quest Diagnostics、LabCorp 和 Bio-Rad Laboratories 等著名參與者，北美將在 2023 年佔據最大佔有率，達到 48.8%。 ，市場。由於職場藥物測試的需求不斷成長及其在醫療保健環境中的應用不斷增加，美國已成為該地區最大的市場。加拿大也發揮著重要作用，醫療保健和職場的藥物檢測顯著成長。此外，北美地區的特點是大麻測試等新興市場，預計這將進一步推動市場擴張。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章全球雇主/職場藥物檢測市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
  • 全球雇主/職場藥物檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章全球雇主/職場藥物檢測市場：類型估計與趨勢分析

  • 細分儀表板
  • 全球雇主/職場藥物檢測市場類型變化分析
  • 2018-2030 年全球雇主/職場藥物檢測市場規模及趨勢分析（按類型）
  • 就業前藥物測試
  • 就業後

第5章全球雇主/職場藥物檢測市場：產品評估與趨勢分析

  • 細分儀表板
  • 全球雇主/職場藥物檢測市場的產品變化分析
  • 2018-2030 年全球雇主/職場藥物檢測市場規模及趨勢分析（依產品）
  • 消耗品
  • 裝置
  • 快速檢測裝置
  • 服務

第6章全球雇主/職場藥物檢測市場：模式估計與趨勢分析

  • 細分儀表板
  • 全球雇主/職場藥物檢測市場模式波動分析
  • 2018-2030 年全球雇主/職場藥物檢測市場規模及趨勢分析（按模式）
  • 尿
  • 頭髮
  • 口腔液
  • 即時測試

第7章全球雇主/職場藥物檢測市場：藥物估計與趨勢分析

  • 細分儀表板
  • 全球雇主/職場藥物檢測市場藥物波動分析
  • 酒精
  • 大麻/大麻
  • 古柯鹼
  • 鴉片類藥物
  • 安非他命/甲基安非他命
  • LSD
  • 其他

第8章全球雇主/職場藥物檢測市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 全球雇主/職場藥物檢測市場的最終用途變化分析
  • 資訊科技/金融
  • 製造業
  • 運輸
  • 建造
  • 零售/酒店業
  • 衛生保健
  • 教育
  • 其他專業服務

第9章雇主/職場藥物檢測市場：區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場佔有率分析
  • 主要身份驗證提供者/方案所有者列表
  • 公司簡介 / 上市公司
    • First Advantage
    • Laboratory Corporation of America Holdings（Labcorp）
    • Dragerwerk AG & Co. KGaA
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • Clinical Reference Laboratory Inc.
    • Quest Diagnostics
    • Cordant Health Solutions
    • DISA Global Solutions
    • HireRight, LLC
    • OraSure Technologies, Inc.
    • Psychemedics Corporation
    • Omega Laboratories
Product Code: GVR-4-68040-463-5

Employer And Workplace Drug Testing Market Growth & Trends:

The global employer and workplace drug testing market size is anticipated to reach USD 7.96 billion by 2030 and is projected to grow at a CAGR of 4.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing focus on maintaining a drug-free workplace to enhance productivity and reduce workplace accidents further propels demand for drug testing services.

The rising prevalence of substance abuse and its associated risks, including impaired performance and increased absenteeism, drives employers to implement comprehensive drug testing programs. Technological advancements in testing methods, such as rapid and accurate detection technologies, contribute to market growth by improving the efficiency and reliability of drug testing processes. Rising government initiative and funding programs is further driving market growth. For instance, in December 2022, the U.S. government enacted the Consolidated Appropriations Act 2023 (Public Law 117-328) (CAA 23). This legislation allocated funds to the Substance Abuse and Mental Health Services Administration (SAMHSA) for the fiscal year 2023 and included various provisions that reinforced, reauthorized, and expanded SAMHSA's programs for substance use disorders and mental health.

Many governments around the world are launching campaigns, providing funding, and establishing programs to promote awareness and prevention of substance abuse in the workplace. These initiatives often include guidelines and frameworks that encourage or mandate drug testing among employees, particularly in industries deemed high-risk. As a result, employers are increasingly adopting drug testing practices to align with government policies and benefit from incentives or funding provided for compliance with these programs.

The demand for employer and workplace drug testing products is further anticipated to increase due to the rigorous enforcement of regulations by various government agencies that mandate drug and alcohol testing for safety purposes. According to the Federal Drug-Free Workplace Program's guidelines, the SAMHSA Center for Substance Abuse Prevention oversees HHS-certified laboratories. These drug-testing programs are required for employees in sensitive roles, such as those in national security, law enforcement, and public health and safety. Both government and non-governmental organizations are implementing strategic initiatives, including new product launches, partnerships, and mergers and acquisitions, to address drug use, which contributes to the growth of the market.

Some of the key players in the market are. First Advantage; Laboratory Corporation of America Holdings (Labcorp); Dragerwerk AG & Co. KGaA; Bio-Rad Laboratories, Inc.; Abbott; Clinical Reference Laboratory Inc.; Quest Diagnostics; Cordant Health Solutions; DISA Global Solutions; HireRight, LLC; OraSure Technologies, Inc.; Omega Laboratories; Psychemedics Corporation and other are adopting key strategic initiatives such as product launches acquisition and launching patent focused resources to cater patients globally. For instance, in May 2024, eMed collaborated with i3screen to introduce a new virtual drug screening program for employers. This innovative service allows companies to conduct drug tests remotely, making the process more convenient and efficient. With this partnership, employers can now offer virtual drug screenings that are easy to administer and provide quick results, helping to streamline their hiring and compliance procedures.

Employer And Workplace Drug Testing Market Report Highlights:

  • Based on type, the post-employment segment led the market with the largest revenue share of 77.9% in 2023. Post-employment drug testing involves screening employees after they have been hired, typically to monitor ongoing compliance with workplace drug policies
  • The consumables segment led the market with the largest revenue share of 33.3% in 2023. Consumables play an important role in drug testing. Market for these products is driven by the need for high-quality and compliant testing solutions, advancements in technology, and the increasing emphasis on maintaining a drug-free workplace. Key players in the market focus on developing and providing a diverse range of consumables to meet the evolving needs of employers and regulatory standards
  • Based on mode, the urine segment led the market with the largest revenue share of 41.5% in 2023. This can be attributed to increasing urine collection for employer and workplace drug testing purposes. A crucial tool for adhering to a prescribed regimen and preventing substance misuse or abuse is Urine Drug Monitoring (UDM)
  • Based on drug, the cannabis/marijuana segment led the market with the largest revenue share of 57.9% in 2023. This is attributable to the legalization of cannabis for medical and recreational use in various countries has led to an increase in employer and workplace drug testing requirements. As more people consume cannabis, employers and healthcare providers are seeking to detect and monitor its use
  • Based on end use, the other professional services segment led the market with the largest revenue share of 38.6% in 2023. Companies across diverse professional services are increasingly adopting drug testing programs to comply with regulatory requirements, manage liability risks, and enhance workplace safety
  • North America dominated the market with the largest revenue share of 48.8% in 2023, due to the presence of a key players and the region hosts a significant number of employer and workplace drug testing laboratories, including prominent players such as Quest Diagnostics, LabCorp, and Bio-Rad Laboratories. The U.S. stands out as the largest market in the region, driven by the rising demand for workplace drug testing and its increasing application in healthcare settings. Canada also plays a key role, with notable growth in drug testing within both healthcare and workplace environments. In addition, the North American region features emerging markets, such as cannabis testing, which is anticipated to further fuel market expansion.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Product Segment
    • 1.2.3. Mode Segment
    • 1.2.4. Drug Segment
    • 1.2.5. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Employer and Workplace Drug Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for pre-employment testing
      • 3.2.1.2. Stringent laws mandating alcohol and drug testing in the workplace
      • 3.2.1.3. Rising prevalence of substance use in the workplace
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Changing legal environment and changing societal norms
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Technological advancement in drug testing for workplace
  • 3.3. Global Employer and Workplace Drug Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Global Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Employer and Workplace Drug Testing Market Type Movement Analysis
  • 4.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by type, 2018 to 2030 (USD Million)
  • 4.4. Pre-employment Drug Screens
    • 4.4.1. Pre-employment drug screens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Post-employment
    • 4.5.1. Post-employment market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Employer and Workplace Drug Testing Market Product Movement Analysis
  • 5.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 5.4. Consumables
    • 5.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Rapid Testing Devices
    • 5.6.1. Rapid testing devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Services
    • 5.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Employer and Workplace Drug Testing Market Mode Movement Analysis
  • 6.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by mode, 2018 to 2030 (USD Million)
  • 6.4. Urine
    • 6.4.1. Urine market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Hair
    • 6.5.1. Hair market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Oral Fluid
    • 6.6.1. Oral fluid market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Instant testing
    • 6.7.1. Instant testing market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Employer and Workplace Drug Testing Market Drug Movement Analysis
    • 7.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by drug, 2018 to 2030 (USD Million)
  • 7.3. Alcohol
    • 7.3.1. Alcohol market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Cannabis/Marijuana
    • 7.4.1. Cannabis/marijuana market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Cocaine
    • 7.5.1. Cocaine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Opioids
    • 7.6.1. Opioids testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Amphetamine & Methamphetamine
    • 7.7.1. Amphetamine & methamphetamine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. LSD
    • 7.8.1. LSD market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Global Employer and Workplace Drug Testing Market: End-use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Employer and Workplace Drug Testing Market End-use Movement Analysis
    • 8.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 8.3. IT/Finance
    • 8.3.1. IT/finance market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Manufacturing
    • 8.4.1. Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Transportation
    • 8.5.1. Transportation market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Construction
    • 8.6.1. Construction market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Retail and Hospitality
    • 8.7.1. Retail and hospitality market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Healthcare
    • 8.8.1. Healthcare market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. Education
    • 8.9.1. Education surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.10. Other Professional Services
    • 8.10.1. Other Professional Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Employer and Workplace Drug Testing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework/ reimbursement structure
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/ reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/ reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/ reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/ reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/ reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/ reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/ reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/ reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/ reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/ reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Share Analysis, 2023
  • 10.4. List of Key Certification Providers/Scheme Owners
  • 10.5. Company Profiles/Listing
    • 10.5.1. First Advantage
      • 10.5.1.1. Company overview
      • 10.5.1.2. Financial performance
      • 10.5.1.3. Product benchmarking
      • 10.5.1.4. Strategic initiatives
    • 10.5.2. Laboratory Corporation of America Holdings (Labcorp)
      • 10.5.2.1. Company overview
      • 10.5.2.2. Financial performance
      • 10.5.2.3. Product benchmarking
      • 10.5.2.4. Strategic initiatives
    • 10.5.3. Dragerwerk AG & Co. KGaA
      • 10.5.3.1. Company overview
      • 10.5.3.2. Financial performance
      • 10.5.3.3. Product benchmarking
      • 10.5.3.4. Strategic initiatives
    • 10.5.4. Bio-Rad Laboratories, Inc.
      • 10.5.4.1. Company overview
      • 10.5.4.2. Financial performance
      • 10.5.4.3. Product benchmarking
      • 10.5.4.4. Strategic initiatives
    • 10.5.5. Abbott
      • 10.5.5.1. Company overview
      • 10.5.5.2. Financial performance
      • 10.5.5.3. Product benchmarking
      • 10.5.5.4. Strategic initiatives
    • 10.5.6. Clinical Reference Laboratory Inc.
      • 10.5.6.1. Company overview
      • 10.5.6.2. Financial performance
      • 10.5.6.3. Product benchmarking
      • 10.5.6.4. Strategic initiatives
    • 10.5.7. Quest Diagnostics
      • 10.5.7.1. Company overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Product benchmarking
      • 10.5.7.4. Strategic initiatives
    • 10.5.8. Cordant Health Solutions
      • 10.5.8.1. Company overview
      • 10.5.8.2. Financial performance
      • 10.5.8.3. Product benchmarking
      • 10.5.8.4. Strategic initiatives
    • 10.5.9. DISA Global Solutions
      • 10.5.9.1. Company overview
      • 10.5.9.2. Financial performance
      • 10.5.9.3. Product benchmarking
      • 10.5.9.4. Strategic initiatives
    • 10.5.10. HireRight, LLC
      • 10.5.10.1. Company overview
      • 10.5.10.2. Financial performance
      • 10.5.10.3. Product benchmarking
      • 10.5.10.4. Strategic initiatives
    • 10.5.11. OraSure Technologies, Inc.
      • 10.5.11.1. Company overview
      • 10.5.11.2. Financial performance
      • 10.5.11.3. Product benchmarking
      • 10.5.11.4. Strategic initiatives
    • 10.5.12. Psychemedics Corporation
      • 10.5.12.1. Company overview
      • 10.5.12.2. Financial performance
      • 10.5.12.3. Product benchmarking
      • 10.5.12.4. Strategic initiatives
    • 10.5.13. Omega Laboratories
      • 10.5.13.1. Company overview
      • 10.5.13.2. Financial performance
      • 10.5.13.3. Product benchmarking
      • 10.5.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 U.S. employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 5 U.S. employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 6 U.S. employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 7 U.S. employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 North America employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 12 North America employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 13 North America employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 16 Canada employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 17 Canada employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 18 Canada employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Mexico employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 Mexico employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 22 Mexico employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 23 Mexico employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 25 Europe employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Europe employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 28 Europe employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 29 Europe employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 UK employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 31 UK employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 32 UK employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 33 UK employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 34 UK employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 36 Germany employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 37 Germany employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 38 Germany employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 39 Germany employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 France employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 41 France employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 42 France employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 43 France employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 44 France employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Italy employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 46 Italy employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 47 Italy employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 48 Italy employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 49 Italy employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Spain employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 Spain employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 52 Spain employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 53 Spain employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 54 Spain employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Denmark employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 56 Denmark employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 57 Denmark employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 58 Denmark employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 59 Denmark employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Sweden employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 61 Sweden employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 62 Sweden employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 63 Sweden employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 64 Sweden employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Norway employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 66 Norway employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Norway employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 68 Norway employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 69 Norway employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Japan employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 77 Japan employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 78 Japan employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 79 Japan employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 80 Japan employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 81 China employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 82 China employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 83 China employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 84 China employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 85 China employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 86 India employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 87 India employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 88 India employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 89 India employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 90 India employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Australia employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 92 Australia employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 93 Australia employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 94 Australia employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 95 Australia employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 97 South Korea employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 98 South Korea employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 99 South Korea employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 100 South Korea employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Thailand employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 102 Thailand employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 103 Thailand employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 104 Thailand employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 105 Thailand employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Latin America employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 107 Latin America employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 108 Latin America employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 109 Latin America employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 110 Latin America employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 111 Latin America employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Brazil employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 113 Brazil employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 114 Brazil employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 115 Brazil employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 116 Brazil employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Argentina employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 118 Argentina employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 119 Argentina employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 120 Argentina employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 121 Argentina employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 122 MEA employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 123 MEA employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 124 MEA employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 125 MEA employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 126 MEA employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 127 MEA employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 128 South Africa employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 129 South Africa employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 130 South Africa employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 131 South Africa employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 132 South Africa employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 138 UAE employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 139 UAE employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 140 UAE employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 141 UAE employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 142 global employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 143 Kuwait employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 144 Kuwait employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 145 Kuwait employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 146 Kuwait employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 147 Kuwait employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Global employer and workplace drug testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Global employer and workplace drug testing market: Type outlook key takeaways
  • Fig. 20 Global employer and workplace drug testing market: Type movement analysis
  • Fig. 21 Pre-employment drug screens market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Post-employment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global employer and workplace drug testing market: Product outlook key takeaways
  • Fig. 24 Global employer and workplace drug testing market: Product movement analysis
  • Fig. 25 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Rapid testing devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Global employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 30 Global employer and workplace drug testing market: Mode movement analysis
  • Fig. 31 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Hair market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Oral fluid market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Instant testing estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Global employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 36 Global employer and workplace drug testing market: Mode movement analysis
  • Fig. 37 Alcohol market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Cannabis/marijuana market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Cocaine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Opioids estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 LSD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Global employer and workplace drug testing market: End-use outlook key takeaways
  • Fig. 45 Global employer and workplace drug testing market: End-use movement analysis
  • Fig. 46 IT/finance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Construction estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Retail and hospitality market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Education market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Other professional services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Employer and Workplace Drug Testing Market: Regional outlook and key takeaways
  • Fig. 55 Regional outlook, 2023 & 2030
  • Fig. 56 North America
  • Fig. 57 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 US key country dynamics
  • Fig. 59 US market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Canada key country dynamics
  • Fig. 61 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Europe
  • Fig. 63 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 UK key country dynamics
  • Fig. 65 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Germany
  • Fig. 67 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 France key country dynamics
  • Fig. 69 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Italy key country dynamics
  • Fig. 71 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Spain key country dynamics
  • Fig. 73 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Denmark key country dynamics
  • Fig. 75 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Sweden key country dynamics
  • Fig. 77 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Norway key country dynamics
  • Fig. 79 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Asia-Pacific
  • Fig. 81 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Japan key country dynamics
  • Fig. 83 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 China key country dynamics
  • Fig. 85 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 India key country dynamics
  • Fig. 87 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 South Korea key country dynamics
  • Fig. 89 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Australia key country dynamics
  • Fig. 91 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Thailand key country dynamics
  • Fig. 93 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Brazil key country dynamics
  • Fig. 97 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Mexico key country dynamics
  • Fig. 99 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Argentina key country dynamics
  • Fig. 101 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Middle East & Africa
  • Fig. 103 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 South Africa key country dynamics
  • Fig. 105 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 Saudi Arabia key country dynamics
  • Fig. 107 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 UAE key country dynamics
  • Fig. 109 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 Kuwait key country dynamics
  • Fig. 111 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Market differentiators
  • Fig. 113 Key company market share analysis, 2023